Authors:
Austin, NE
Avenell, KY
Boyfield, I
Branch, CL
Hadley, MS
Jeffrey, P
Johnson, CN
Macdonald, GJ
Nash, DJ
Riley, GJ
Smith, AB
Stemp, G
Thewlis, KM
Vong, AKK
Wood, MD
Citation: Ne. Austin et al., Design and synthesis of novel 2,3-dihydro-1H-isoindoles with high affinityand selectivity for the dopamine D-3 receptor, BIOORG MED, 11(5), 2001, pp. 685-688
Authors:
Calver, AR
Robbins, MJ
Cosio, C
Rice, SQJ
Babbs, AJ
Hirst, WD
Boyfield, I
Wood, MD
Russell, RB
Price, GW
Couve, A
Moss, SJ
Pangalos, MN
Citation: Ar. Calver et al., The C-terminal domains of the GABA(B) receptor subunits mediate intracellular trafficking but are not required for receptor signaling, J NEUROSC, 21(4), 2001, pp. 1203-1210
Authors:
Austin, NE
Avenell, KY
Boyfield, I
Branch, CL
Hadley, MS
Jeffrey, P
Johnson, CN
Macdonald, GJ
Nash, DJ
Riley, GJ
Smith, AB
Stemp, G
Thewlis, KM
Vong, AKK
Wood, M
Citation: Ne. Austin et al., Novel 2,3,4,5-tetrahydro-1H-3-benzazepines with high affinity and selectivity for the dopamine D-3 receptor, BIOORG MED, 10(22), 2000, pp. 2553-2555
Authors:
Reavill, C
Boyfield, I
Coldwell, M
Nelson, P
Citation: C. Reavill et al., Comparative pharmacological study of ropinirole (SKF-101468) and its metabolites in rats, J PHARM PHA, 52(9), 2000, pp. 1129-1135
Authors:
Reavill, C
Taylor, SG
Wood, MD
Ashmeade, T
Austin, NE
Avenell, KY
Boyfield, I
Branch, CL
Cilia, J
Coldwell, MC
Hadley, MS
Hunter, AJ
Jeffrey, P
Jewitt, F
Johnson, CN
Jones, DNC
Medhurst, AD
Middlemiss, DN
Nash, DJ
Riley, GJ
Routledge, C
Stemp, G
Thewlis, KM
Trail, B
Vong, AKK
Hagan, JJ
Citation: C. Reavill et al., Pharmacological actions of a novel, high-affinity, and selective human dopamine D-3 receptor antagonist, SB-277011-A, J PHARM EXP, 294(3), 2000, pp. 1154-1165
Authors:
Stemp, G
Ashmeade, T
Branch, CL
Hadley, MS
Hunter, AJ
Johnson, CN
Nash, DJ
Thewlis, KM
Vong, AKK
Austin, NE
Jeffrey, P
Avenell, KY
Boyfield, I
Hagan, JJ
Middlemiss, DN
Reavill, C
Riley, GJ
Routledge, C
Wood, M
Citation: G. Stemp et al., Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D-3 receptor antagonist with high oral bioavailability and CNS penetration in the rat, J MED CHEM, 43(9), 2000, pp. 1878-1885
Authors:
Wood, MD
Boyfield, I
Nash, DJ
Jewitt, FR
Avenell, KY
Riley, GJ
Citation: Md. Wood et al., Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor, EUR J PHARM, 407(1-2), 2000, pp. 47-51
Authors:
Austin, NE
Avenell, KY
Boyfield, I
Branch, CL
Coldwell, MC
Hadley, MS
Jeffrey, P
Johns, A
Johnson, CN
Nash, DJ
Riley, GJ
Smith, SA
Stacey, RC
Stemp, G
Thewlis, KM
Vong, AKK
Citation: Ne. Austin et al., Novel 1,2,3,4-tetrahydroisoquinolines with high affinity and selectivity for the dopamine D-3 receptor, BIOORG MED, 9(2), 1999, pp. 179-184
Authors:
Avenell, KY
Boyfield, I
Hadley, MS
Johnson, CN
Nash, DJ
Riley, GJ
Stemp, G
Citation: Ky. Avenell et al., Heterocyclic analogues of 2-aminotetralins with high affinity and selectivity for the dopamine D-3 receptor, BIOORG MED, 9(18), 1999, pp. 2715-2720
Authors:
Coldwell, MC
Boyfield, I
Brown, T
Hagen, JJ
Middlemiss, DN
Citation: Mc. Coldwell et al., Comparison of the functional potencies of ropinirole and other dopamine receptor agonists at human D-2(long), D-3 and D-4.4 receptors expressed in Chinese hamster ovary cells, BR J PHARM, 127(7), 1999, pp. 1696-1702
Authors:
Coldwell, MC
Boyfield, I
Brown, AM
Stemp, G
Middlemiss, DN
Citation: Mc. Coldwell et al., Pharmacological characterization of extracellular acidification rate responses in human D-2(long), D-3 and D-4.4 receptors expressed in Chinese hamster ovary cells, BR J PHARM, 127(5), 1999, pp. 1135-1144